Corindus Vascular Robotics, Inc. (CVRS) EPS Estimated At $-0.07

July 14, 2018 - By Elena Maslow

Corindus Vascular Robotics, Inc. (NYSEAMERICAN:CVRS) Logo

Analysts expect Corindus Vascular Robotics, Inc. (NYSEAMERICAN:CVRS) to report $-0.07 EPS on August, 14.They anticipate $0.03 EPS change or 75.00 % from last quarter’s $-0.04 EPS. After having $-0.08 EPS previously, Corindus Vascular Robotics, Inc.’s analysts see -12.50 % EPS growth. The stock decreased 3.67% or $0.04 during the last trading session, reaching $1.05. About 526,593 shares traded. Corindus Vascular Robotics, Inc. (NYSEAMERICAN:CVRS) has declined 33.09% since July 14, 2017 and is downtrending. It has underperformed by 45.66% the S&P500.

Corindus Vascular Robotics, Inc. designs, makes, and sells robotic-assisted precision vascular intervention systems for use in interventional vascular procedures. The company has market cap of $198.23 million. The firm offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures. It currently has negative earnings. The Company’s CorPath system facilitates stent positioning for PCI procedures by allowing a physician to measure, manipulate, and advance devices with robotic precision; and CorPath GRX system enables the precise, robotic-assisted control of coronary guide catheters, guidewires, and balloon/stent devices from the safety of a radiation-shielded interventional cockpit.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.